Drugs / Pemebit
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02498860 | Sep 2015 → Feb 2018 | adenocarcinoma, lung neoplasm | Chonnam National University Hospital | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pemebit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02498860 ↗ |